HIV-1 Treatment Failure and Acquiring Drug Resistance Among First Line Antiretroviral Experienced Patients in Ethiopia, 2017
| Id | EPHI-DS0098 |
|---|---|
| Name | HIV-1 Treatment Failure and Acquiring Drug Resistance Among First Line Antiretroviral Experienced Patients in Ethiopia, 2017 |
| Format | . SAV |
| Coverage Location | National (All regional states of Ethiopia) |
| Coverage Sex | Both |
| Abstract | Treatment failure (TF) among patients receiving antiretroviral therapy (ART) against human immunodeficiency virus (HIV) impacts treatment outcomes is becoming a public health concern globally. However, the magnitude of TF and factors leading to it are poorly defined in the context of Ethiopia. Thus, the aim of this study was to determine the magnitude of TF and assess its determinants among HIV-infected patients on ART in Ethiopia. A prospective and retrospective study was conducted from March 2016 to 2017. Retrospective clinical and laboratory data were captured from patients’ medical records. On the other hand, socio-demographics and explanatory variables of participants were collected using pre-tested structured questionnaire and study participants were followed for additional 6 months after baseline viral load has been done to classify virologic failure (VF). Multiple logistic regression was conducted to assess risk factors associated with TF. Statistical significance was set at P-value less than 0.05. |
| Additional Material | No |
| Keywords |
|
| Recommended | Yes |
| Location | |
| Cleaned | Yes |
| Cleaned Format | . csdb |
| RawFormat | . csdb |
| Comment | |
| Remark | |
| Note | |
| Treatment | |
| Date Data Collection Started | 2016-03-01 |
| Date Data Collection End | 2017-05-29 |
| Title | HIV-1 Treatment Failure and Acquiring Drug Resistance Among First Line Antiretroviral Experienced Patients in Ethiopia, 2017 |
| Data Type | Laboratory |
| PublicationYear | 2019 |
| SugestedCitation | Getaneh Y, Egziabhier AG, Zealiyas K, Tilahun R, Girma M, Michael GG, et al. HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia. J AIDS HIV Treat. 2019; 1(2):46-57. |
| OtherIdType | |
| Description | A retrospective and prospective follow-up study was conducted across the nationally representative Health Facilities (HFs) in Ethiopia. Baseline VL testing was done followed by second-round VL testing after three to six months of intensive adherence counseling for patients with VL>1000 copies/ml at baseline to determine Treatment Failure (TF) as defined by WHO-2013. Pre-established tools and questioner were also used to assess determinants of TF. HFs providing ART service for at least 60 patients and with at least 9 months of ART service experience was part of this study. Study participants within the HFs were those who had at least 9-month ART experience. |
| Dataset study design | Randomized controlled trial |
| Date Data Archived | 2019-09-20 |
| Date Data Cataloged | 2020-05-19 |
| Data Generating Unit | HIV and TB Research Directorate |
| URL | https://rtds.ephi.gov.et/public/showdetail/98 |
| Tags |
|
Open Access
